Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with rifaximin

P Lutz1, M Parcina, I Bekeredjian-Ding

  • 1Department of Internal Medicine I, University of Bonn, Sigmund-Freud-Str. 25, 53129, Bonn, Germany, philipp.lutz@ukb.uni-bonn.de.

Infection
|March 26, 2013
PubMed

Insights

Spontaneous bacterial peritonitis (SBP) can occur despite rifaximin prophylaxis. This case highlights uncommon pathogens like Pasteurella multocida, often from pets, causing SBP, which still responds to antibiotics.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Microbiology

Background:

  • Spontaneous bacterial peritonitis (SBP) is a serious complication in liver cirrhosis patients.
  • Rifaximin, a non-absorbable antibiotic, is used for hepatic encephalopathy and proposed for SBP prophylaxis.
  • This study examines an SBP case occurring during rifaximin prophylaxis.

Observation:

  • A liver cirrhosis patient on rifaximin prophylaxis presented with ascites and abdominal pain.
  • Paracentesis revealed SBP caused by Pasteurella multocida.
  • The patient's cat was identified as the likely source of Pasteurella multocida infection.

Findings:

  • Pasteurella multocida, an uncommon SBP pathogen, was identified.
  • The isolated pathogen was sensitive to multiple antibiotics, including rifaximin.
  • Ceftriaxone treatment led to rapid resolution of SBP.

Implications:

  • Awareness of unusual pathogens and transmission routes for SBP is crucial, even with prophylaxis.
  • Non-absorbable antibiotic prophylaxis does not eliminate all SBP risks.
  • Systemic antibiotic therapy remains effective for SBP caused by sensitive organisms.